Latest News for: antibes

Edit

Antibe Provides Update on CCAA Proceedings

Business Wire 19 Apr 2024
TORONTO--(BUSINESS WIRE)---- $ATBPF--Antibe Provides Update on CCAA Proceedings ... .
Edit

Antibe Announces TSX Delisting Review

Business Wire 16 Apr 2024
TORONTO--(BUSINESS WIRE)--Antibe Announces TSX Delisting Review ... .
Edit

Antibe Announces Granting of Initial Order Under Companies' Creditors Arrangement Act

Business Wire 10 Apr 2024
TORONTO--(BUSINESS WIRE)---- $ATBPF--Antibe Announces Granting of Initial Order under Companies' Creditors Arrangement Act ... .
Edit

Antibe to File an Application for an Initial Order Under Companies' Creditors Arrangement Act

Business Wire 09 Apr 2024
TORONTO--(BUSINESS WIRE)---- $ATBPF--Antibe to File an Application for an Initial Order under Companies' Creditors Arrangement Act ... .
Edit

Antibe to Present Otenaproxesul PK/PD Results at the ASRA Pain Medicine Meeting

Business Wire 20 Mar 2024
TORONTO--(BUSINESS WIRE)---- $ATBPF--ANTIBE TO PRESENT OTENAPROXESUL PK/PD RESULTS AT THE ASRA PAIN MEDICINE MEETING ... .
Edit

Antibe to Present Otenaproxesul PK/PD Results at the American Academy of Pain Medicine Meeting

Business Wire 07 Mar 2024
TORONTO--(BUSINESS WIRE)---- $ATBPF--ANTIBE TO PRESENT OTENAPROXESUL PK/PD RESULTS AT THE AMERICAN ACADEMY OF PAIN MEDICINE MEETING ... .
Edit

Antibe Announces Unfavorable Decision in Arbitration With Nuance Pharma

Business Wire 04 Mar 2024
TORONTO--(BUSINESS WIRE)---- $ATBPF--Antibe Announces Unfavorable Decision in Arbitration With Nuance Pharma ... .
Edit

Antibe Therapeutics Shares Sink After Arbitration Case Lost

Market Watch 04 Mar 2024
Antibe Therapeutics' shares were down sharply after the biotechnology company lost a dispute in arbitration over a license agreement for the commercialization of its lead drug candidate in the Greater China region.
Edit

Antibe Reports Q3 2024 Interim Financial and Operating Results

Business Wire 14 Feb 2024
TORONTO--(BUSINESS WIRE)---- $ATBPF--ANTIBE REPORTS Q3 2024 INTERIM FINANCIAL AND OPERATING RESULTS ... .
Edit

Antibe Therapeutics Announces Amendment to Warrant Terms

Business Wire 12 Dec 2023
TORONTO--(BUSINESS WIRE)---- $ATBPF--Antibe Announces Amendment to Warrant Terms ... .
×